E-LIB Suche - Ergebnisse für: Wei-Xiong Xia

1

Oral JS-38, a metabolite from Xenorhabdus sp., has both ant..:

LIU, Min-Yu ; XIAO, Lin ; CHEN, Geng-Hui...
Chinese Journal of Natural Medicines. 12 (2014) 10 - p. 768-776 , 2014

Link: https://doi.org/10.1016/..

2

Toripalimab plus capecitabine in the treatment of patients ..:

Cao, Xun ; Huang, Hao-Yang ; Liang, Chi-Xiong...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Nab-paclitaxel, cisplatin, and capecitabine versus cisplati..:

Liu, Guo-Ying ; Ye, Yan-Fang ; Jiang, Yao-Fei...
BMJ. , 2024

Link: https://doi.org/10.1136/..

4

Camrelizumab and apatinib plus induction chemotherapy and c..:

Liang, Hu ; Jiang, Yao-Fei ; Liu, Guo-Ying...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Development of a prognostic model to identify the metastati..:

Liu, Guo-Ying ; Lu, Nian ; Bei, Wei-Xin...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Tumor residue in patients with stage II–IVA nasopharyngeal ..:

Huang, Ying-Ying ; Zhou, Jia-Yu ; Zhan, Ze-Jiang...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Efficacy and safety of sintilimab plus bevacizumab in metas..:

Lu, Nian ; Jiang, Yao-Fei ; Xia, Wei-Xiong...
eClinicalMedicine. 62 (2023) - p. 102136 , 2023

Link: https://doi.org/10.1016/..

8

A deep learning-based semiautomated workflow for triaging f..:

Huang, Ying-Ying ; Deng, Yi-Shu ; Liu, Yang...
iScience. 26 (2023) 12 - p. 108347 , 2023

Link: https://doi.org/10.1016/..

9

Development of a prognostic model to identify the metastati..:

Guo-Ying Liu ; Nian Lu ; Wei-Xin Bei...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1069010/full. , 2023

Link: https://doi.org/10.3389/..

10

A deep learning-based semiautomated workflow for triaging f..:

Ying-Ying Huang ; Yi-Shu Deng ; Yang Liu...
http://www.sciencedirect.com/science/article/pii/S2589004223024240. , 2023

Link: https://doi.org/10.1016/..

11

DataSheet_1_Development of a prognostic model to identify t..:

Guo-Ying Liu ; Nian Lu ; Wei-Xin Bei...
doi:10.3389/fimmu.2023.1069010.s001. , 2023

Link: https://doi.org/10.3389/..

12

Tumor residue in patients with stage II–IVA nasopharyngeal ..:

Ying-Ying Huang ; Jia-Yu Zhou ; Ze-Jiang Zhan...
https://doi.org/10.1186/s12885-023-10827-0. , 2023

Link: https://doi.org/10.1186/..

13

Efficacy and safety of sintilimab plus bevacizumab in metas..:

Nian Lu ; Yao-Fei Jiang ; Wei-Xiong Xia...
http://www.sciencedirect.com/science/article/pii/S2589537023003139. , 2023

Link: https://doi.org/10.1016/..

14

Plasma Circulating Tumor Epstein–Barr Virus for the Surveil..:

Liu, Guo-Ying ; Xia, Wei-Xiong ; Bi, Zhuo-Fei...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

15

Plasma Circulating Tumor Epstein–Barr Virus for the Surveil..:

Guo-Ying Liu ; Wei-Xiong Xia ; Zhuo-Fei Bi...
https://www.frontiersin.org/articles/10.3389/fonc.2022.860700/full. , 2022

Link: https://doi.org/10.3389/..